Product development of the oxygen-removal device, commercialization, partnerships with bottle manufacturers, and expansion of research and clinical validation.
Lead Investor
Empirical Ventures
Alle Investoren (6)
Empirical VenturesLead
The Helm
XFactor Ventures
Lavender Ventures
Kayan Ventures
Evenlode Investment
Analyse-Artikel
BoobyBiome sichert £2,5 Mio. Seed-Finanzierung zur Erhaltung des Muttermilch-Mikrobioms